Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

624
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
624

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Partner change, birth interval and risk of pre-eclampsia: a paradoxical triangle.

Paediatric and perinatal epidemiology·2007
Same author

Partner change and perinatal outcomes: a systematic review.

Paediatric and perinatal epidemiology·2007
Same author

A controversial tumor marker: is SM22 a proper biomarker for gastric cancer cells?

Journal of proteome research·2007
Same author

A strategy for high-throughput analysis of levosimendan and its metabolites in human plasma samples using sequential negative and positive ionization liquid chromatography/tandem mass spectrometric detection.

Rapid communications in mass spectrometry : RCM·2007
Same author

[Leukemic cell apoptosis induced by anti-human DR5 monoclonal antibody mDRA-6].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology·2007
Same author

[Infection of intervertebral space and the interventional therapy].

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences·2007

Related Experiment Video

Updated: Jan 6, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

468

A prognostic model for gastric cancer constructed by multiple machine learning algorithms.

Xueli Yang1,2,3,4, Xu Huang1,2,3,4, Wang Ying1,2,3,4

  • 1Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, People's Republic of China.

Journal of Molecular Histology
|October 14, 2025
PubMed
Summary

This study developed a machine learning risk model using 7 hub genes to predict gastric cancer (GC) prognosis. The model accurately identifies high-risk patients, aiding personalized treatment strategies for this heterogeneous disease.

Keywords:
BiomarkersGastric cancer (GC)Machine learningPrognosis

More Related Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.2K

Related Experiment Videos

Last Updated: Jan 6, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

468
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.2K

Area of Science:

  • Oncology
  • Bioinformatics
  • Computational Biology

Background:

  • Gastric cancer (GC) is a heterogeneous disease with variable prognoses.
  • Accurate prognostic models are crucial for effective patient management.
  • Machine learning offers powerful tools for biomarker discovery and prognostic model development.

Purpose of the Study:

  • To integrate bioinformatics and machine learning to construct a predictive risk model for GC prognosis.
  • To identify novel prognostic biomarkers for gastric cancer.
  • To validate the model's predictive accuracy and its potential as an independent prognostic factor.

Main Methods:

  • Utilized TCGA and GEO databases for transcriptome and clinical data.
  • Employed univariate Cox regression and machine learning (RSF, GBM) to screen prognostic hub genes.
  • Validated the risk model using Kaplan-Meier curves, ROC analysis, and Cox regression.
  • Assessed protein expression of hub genes via immunohistochemistry.

Main Results:

  • Identified 7 hub genes (CGB5, FEM1A, MATN3, ZNF101, MARCKS, BRI3BP, APOD) significantly correlated with GC prognosis.
  • Developed a high-precision risk model demonstrating good predictive ability for GC patient outcomes.
  • Found elevated protein expression of CGB5, MATN3, MARCKS, and APOD in GC tissues, correlating with pathological characteristics.
  • The risk score derived from the model served as an independent prognostic factor.

Conclusions:

  • The 7-hub-gene risk model accurately predicts gastric cancer prognosis.
  • This model can serve as an independent prognostic indicator for GC patients.
  • Findings support the potential for precise and personalized treatment strategies in gastric cancer.